Early Introduction and Community Transmission of SARS-CoV-2 Omicron Variant, New York, New York, USA
The Omicron variant of SARS-CoV-2 has become dominant in most countries and has raised significant global health concerns. As a global commerce center, New York, New York, USA, constantly faces the risk for multiple variant introductions of SARS-CoV-2. To elucidate the introduction and transmission of the Omicron variant in the city of New York, we created a comprehensive genomic and epidemiologic analysis of 392 Omicron virus specimens collected during November 25-December 11, 2021. We found evidence of 4 independent introductions of Omicron subclades, including the Omicron subclade BA.1.1 with defining substitution of R346K in the spike protein. The continuous genetic divergence within each Omicron subclade revealed their local community transmission and co-circulation in New York, including both household and workplace transmissions supported by epidemiologic evidence. Our study highlights the urgent need for enhanced genomic surveillance and effective response planning for better prevention and management of emerging SARS-CoV-2 variants.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
Emerging infectious diseases - 29(2023), 2 vom: 13. Feb., Seite 371-380 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Liu, Dakai [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 26.01.2023 Date Revised 13.05.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.3201/eid2902.220817 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM352031182 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM352031182 | ||
| 003 | DE-627 | ||
| 005 | 20231226052807.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3201/eid2902.220817 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1173.xml |
| 035 | |a (DE-627)NLM352031182 | ||
| 035 | |a (NLM)36692451 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Liu, Dakai |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Early Introduction and Community Transmission of SARS-CoV-2 Omicron Variant, New York, New York, USA |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.01.2023 | ||
| 500 | |a Date Revised 13.05.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The Omicron variant of SARS-CoV-2 has become dominant in most countries and has raised significant global health concerns. As a global commerce center, New York, New York, USA, constantly faces the risk for multiple variant introductions of SARS-CoV-2. To elucidate the introduction and transmission of the Omicron variant in the city of New York, we created a comprehensive genomic and epidemiologic analysis of 392 Omicron virus specimens collected during November 25-December 11, 2021. We found evidence of 4 independent introductions of Omicron subclades, including the Omicron subclade BA.1.1 with defining substitution of R346K in the spike protein. The continuous genetic divergence within each Omicron subclade revealed their local community transmission and co-circulation in New York, including both household and workplace transmissions supported by epidemiologic evidence. Our study highlights the urgent need for enhanced genomic surveillance and effective response planning for better prevention and management of emerging SARS-CoV-2 variants | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Cheng Y | |
| 650 | 4 | |a Fiel RH | |
| 650 | 4 | |a Gruenstein Y | |
| 650 | 4 | |a New York | |
| 650 | 4 | |a Omicron | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Suggested citation for this article: Liu D | |
| 650 | 4 | |a USA. Emerg Infect Dis. 2023 Feb [date cited]. https://doi.org/10.3201/eid2902.220817 | |
| 650 | 4 | |a United States | |
| 650 | 4 | |a Wang L | |
| 650 | 4 | |a Zhou H | |
| 650 | 4 | |a co-circulation | |
| 650 | 4 | |a community transmission | |
| 650 | 4 | |a et al. Early introduction and community transmission of SARS-CoV-2 Omicron variant | |
| 650 | 4 | |a household transmission | |
| 650 | 4 | |a respiratory infections | |
| 650 | 4 | |a subclade multiple introductions | |
| 650 | 4 | |a viruses | |
| 650 | 4 | |a workplace transmission | |
| 650 | 4 | |a zoonoses | |
| 700 | 1 | |a Cheng, Yexiao |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Hangyu |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Lulan |e verfasserin |4 aut | |
| 700 | 1 | |a Fiel, Roberto Hurtado |e verfasserin |4 aut | |
| 700 | 1 | |a Gruenstein, Yehudah |e verfasserin |4 aut | |
| 700 | 1 | |a Luo, Jean Jingzi |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Vishnu |e verfasserin |4 aut | |
| 700 | 1 | |a Konadu, Eric |e verfasserin |4 aut | |
| 700 | 1 | |a James, Keither |e verfasserin |4 aut | |
| 700 | 1 | |a Lui, Calvin |e verfasserin |4 aut | |
| 700 | 1 | |a Gao, Pengcheng |e verfasserin |4 aut | |
| 700 | 1 | |a Urban, Carl |e verfasserin |4 aut | |
| 700 | 1 | |a Prasad, Nishant |e verfasserin |4 aut | |
| 700 | 1 | |a Segal-Maurer, Sorana |e verfasserin |4 aut | |
| 700 | 1 | |a Wurzberger, Esther |e verfasserin |4 aut | |
| 700 | 1 | |a Cheng, Genhong |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Aiping |e verfasserin |4 aut | |
| 700 | 1 | |a Rodgers, William Harry |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Emerging infectious diseases |d 1995 |g 29(2023), 2 vom: 13. Feb., Seite 371-380 |w (DE-627)NLM088704254 |x 1080-6059 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2023 |g number:2 |g day:13 |g month:02 |g pages:371-380 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3201/eid2902.220817 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2023 |e 2 |b 13 |c 02 |h 371-380 | ||